← Back to Home

DOJOLVI® (triheptanoin) for LC-FAOD

dojolvi.com 🇺🇸 EN-US

DOJOLVI® (triheptanoin) is the first and only FDA-approved treatment for patients diagnosed with long-chain fatty acid oxidation disorders (LC-FAOD)

Categories

Industries: healthcare
Types: corporate

Tech Stack

Color Palette

Primary #282e3c
Accent #f59e0b
Background #ffffff
Secondary 1 #007bff
Secondary 2 #00d0bc

Contact Information

Phone: +1-800-555-1234
Social Media:

Full Screenshot

DOJOLVI® (triheptanoin) for LC-FAOD - Full Screenshot
Loading...